Kurt

 


Home
Portfolio
CV
Research
Publications & Presentations
scrap
blog
Contact Me

     Related Pages

Christensen KD, Roberts JS, Zikmund-Fisher BJ, Kardia SLR, McBride CM, Linnenbringer E, & Green RC. (in press). Associations between self-referral and health behavior responses to genetic risk information. Genome Medicine.

McLaughlin HM, Ceyhan-Birsoy O, Christensen KD, et al. A systematic approach to the return of medically relevant findings from whole genome sequencing. (in press). BMC Medical Genetics.

Kahn CM, Rini C, Bernhardt BA, Roberts JS, Christensen KD, et al. (in press). How can psychological science inform questions about clinical genomic sequencing? Journal of Genetic Counseling. doi:10.1007/s10897-014-9804-6

Green RC, Christensen KD, Cupples LA, Relkin NR, Whitehouse PJ, Royal CDM, et al. (in press). A randomized non-inferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease. Alzheimer's and Dementia.

Vassy JL, Christensen KD, Slashinski MJ, Lautenbach DM, Robinson JO, Blumenthal-Barby J, et al. (in press). 'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care. Personalized Medicine.

Besser AG, Sanderson SC, Roberts JS, Chen CA, Christensen KD, et al. (in press). Factors affecting recall of different types of personal genetic information about Alzheimer's disease risk: the REVEAL Study. Public Health Genomics.

Gray SW, Martins Y, Feuerman LZ, Bernhardt BA, Biesecker BB, Christensen KD, et al. (2014). Social and behavioral research in genomic sequencing-approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group. Genetics in Medicine, 16(10), 727-735. doi:10.1038/gim.2014.26

Christensen KD, Kalia SS, & Green RC. (2014). Incidental findings from genetic testing. In UpToDate, Raby BA (Ed), UpToDate, Waltham, MA. (Summary)

Vassy JL, Lautenbach DM, McLaughlin HM, Kong SW, Christensen KD, et al. (2014). The MedSeq Project: A randomized trial of integrating whole genome sequencing into clinical medicine. Trials, 15, 85. doi:10.1186/1745-6215-15-85

Lautenbach DM, Christensen KD, Sparks JA, & Green RC. (2013). Communicating genetic risk information for common disorders in the era of genomic medicine. Annual Review of Genomics and Human Genetics, 14, 491-513. doi:10.1146/annurev-genom-092010-110722

Christensen KD, & Green RC. (2013). How could disclosing incidental information from whole-genome sequencing affect patient behavior? Personalized Medicine, 10(4), 377-386. doi: 10.2217/pme.13.24

Terry SF, Christensen KD, Metosky S, Rudofsky G, Deignan KP, Martinez H, Johnson-Moore P, Citrin T. (2012). Methods of public engagement about genetic variation research. Population Health Management, 15(2) 78-89. doi:10.1089/pop.2011.0013

Roberts JS, Christensen KD, & Green RC. (2011). Using Alzheimer's disease as a model for genetic risk disclosure: Implications for personal genomics. Clinical Genetics, 80(5), 407-414. doi: 10.1111/j.1399-0004.2011.01739.x

Christensen KD, Roberts JS, Uhlmann WR, & Green RC. (2011). Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer's disease risk. Genetics in Medicine, 13(5), 409-414. doi:10.1097/GIM.0b013e3182076bf1

Hock KT, Christensen KD, Yashar BM, Roberts JS, Gollust SE, & Uhlmann WR (2011). Direct-to-consumer genetic testing: An assessment of genetic counselors' knowledge and beliefs. Genetics in Medicine 13(4), 325-332. doi:10.1097/GIM.0b013e3182011636

Christensen KD, Roberts JS, Shalowitz DI, Everett JN, Kim SYH, Raskin L, & Gruber SB. (2011). Disclosing individual CDKN2A research results to melanoma survivors: Interest, impact, and demands on researchers. Cancer Epidemiology, Biomarkers & Prevention, 20(3), 522-529. doi:10.1158/1055-9965.EPI-10-1045

Christensen KD, Jayaratne, TE, Roberts JS, Kardia, SLR, & Petty EM. (2010). Understanding of basic genetics in the United States: Results from a national survey of black and white men and women. Public Health Genomics, 13(7-8), 467-476. doi:10.1159/000293287

Roberts JS, Shalowitz DI, Christensen KD, Everett JN, Kim SYH, Raskin L, et al. (2010). Returning individual research results: Development of a cancer genetics education and risk communication protocol. Journal of Empirical Research on Human Research Ethics, 5(3), 17-30. doi:10.1525/jer.2010.5.3.17

Christensen KD, Roberts JS, Royal CDM, Fasaye G, Obisesan T, Cupples LA, et al. (2008). Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL Study experience. Genetics in Medicine, 10(3), 207-214. doi:10.1097/GIM.0b013e318164e4cf

Harvey EK, Fogel CE, Peyrot M, Christensen KD, Terry SF, & McInerney JD. (2007). Providers' knowledge of genetics: A survey of 5915 individuals and families with genetic conditions. Genetics in Medicine, 9(5), 259-267. doi:10.1097/GIM.0b013e31805002f2

 

Member of an investigative team cited in the acknowledgments or appendix

Kong SW, Lee I, Leshchiner I, Krier J, Kraft P, Rehm HL, Green RC, Kohane IS, & MacRae CA. (in press). Summarizing polygenic risks for complex diseases in a clinical whole-genome report. Genetics in Medicine. doi:10.1038/gim.2014.143

Carere DA, Couper MP, Crawford SD, et al. (2014). Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers. Genome Medicine, 6(12):96. doi:10.1186/s13073-014-0096-0

Roberts JS, Chen CA, Uhlmann WR, & Green RC. (2012). Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease. Genetics in Medicine, 14(8):742-8. doi:10.1038/gim.2012.37